Biologic drug offers promising protection against alpha-gal syndrome
The summer of 2026 was a particularly bad season for ticks. And with it came a rising number…
FDA Confirms Direct Review Path For Aquestive’s Allergy Treatment
The U.S. Food and Drug Administration (FDA) on Thursday informed Aquestive Therapeutics, Inc. (NASDAQ:AQST) that an advisory committee…